Mass screening of prostate cancer and its impact on inhabitants in Akita Prefecture, Japan
- PMID: 20094956
- DOI: 10.1055/s-0029-1224653
Mass screening of prostate cancer and its impact on inhabitants in Akita Prefecture, Japan
Abstract
In 2001, the Akita Medical Association started a prostate cancer (PC) mass screening project for >or= 50-year-old male inhabitants in individual municipalities of Akita Prefecture, utilizing serum prostate-specific antigen. The number of examinees increased from 4321 in 2001 to 29,936 in 2006, while the annual rate of examinees per target inhabitants remained at 11.6 to 16.8% and the fraction of repeat examinees increased up to 77% in 2006. A total of 944 PCs were screened with a stage B tumor incidence of 84.1% (range: 82.2 to 86.6%). The annual PC detection rate was 0.95 to 1.11% for the first 4 years, but then declined to 0.54% in 2006 mainly due to the increase of repeat examinees. PSA mass screening is effective for the detection of early stage PC, but a further promotion is needed to mobilize the sleeping inhabitants. Indeed, the number of new PC patients in 17 major hospitals in Akita Prefecture rapidly increased after the mass screening started (3.2-fold), suggesting an enlightenment effect of the screening project on both the inhabitants and general physicians.
Similar articles
-
[Prostate tumor and its diagnosis].Rinsho Byori. 2001 Jul;49(7):633-7. Rinsho Byori. 2001. PMID: 11519121 Review. Japanese.
-
Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.Cancer. 2005 Jan 15;103(2):242-50. doi: 10.1002/cncr.20739. Cancer. 2005. PMID: 15578715
-
[Mass screening for prostate cancer in Japan].Nihon Rinsho. 1996 May;54(5):1447-51. Nihon Rinsho. 1996. PMID: 8965383 Review. Japanese.
-
First year of mass screening for prostatic cancer in Yaizu city.Aktuelle Urol. 2003 Jul;34(4):242-3. doi: 10.1055/s-2003-41605. Aktuelle Urol. 2003. PMID: 14566673
-
[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].Prog Urol. 2009 Jul;19(7):487-98. doi: 10.1016/j.purol.2009.03.001. Epub 2009 Apr 28. Prog Urol. 2009. PMID: 19559380 Clinical Trial. French.
Cited by
-
Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.Asian J Androl. 2015 May-Jun;17(3):475-80. doi: 10.4103/1008-682X.143756. Asian J Androl. 2015. PMID: 25578935 Free PMC article. Review.
-
Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan.Asian J Androl. 2014 Nov-Dec;16(6):833-7. doi: 10.4103/1008-682X.135122. Asian J Androl. 2014. PMID: 25219906 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous